IDXX - Idexx Laboratories, Inc.
IEX Last Trade
481.36
-5.920 -1.230%
Share volume: 406,337
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$487.28
-5.92
-1.22%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-01 | 2023-02-16 | 2023-05-02 | 2023-08-01 | 2023-11-01 | 2024-02-22 | 2024-05-01 | |
| Assets | |||||||||
| Total Assets | 2.607 B | 2.640 B | 2.747 B | 2.808 B | 2.871 B | 3.086 B | 3.260 B | 3.354 B | |
| Current Assets | 1.043 B | 1.059 B | 1.101 B | 1.149 B | 1.179 B | 1.384 B | 1.495 B | 1.502 B | |
| Inventories | 332.565 M | 354.975 M | 367.823 M | 391.011 M | 395.141 M | 393.974 M | 380.282 M | 390.599 M | |
| Other Current Assets | 163.146 M | 194.066 M | 172.059 M | 173.851 M | 168.883 M | 187.649 M | 186.623 M | 192.274 M | |
| Short Term Investments | 163.146 M | 194.066 M | 172.059 M | 173.851 M | 168.883 M | 187.649 M | 186.623 M | 192.274 M | |
| Total Receivables | 432.752 M | 410.642 M | 449.049 M | 473.217 M | 482.163 M | 470.911 M | 474.417 M | 521.667 M | |
| Current Cash | 114.362 M | 99.176 M | 112.546 M | 111.367 M | 132.838 M | 331.696 M | 453.932 M | 397.433 M | |
| Total Non-current Assets | 1.564 B | 1.581 B | 1.645 B | 1.659 B | 1.692 B | 1.702 B | 1.765 B | 1.852 B | |
| Property Plant Equipment | 594.224 M | 612.405 M | 649.474 M | 665.439 M | 683.270 M | 687.101 M | 702.177 M | 708.725 M | |
| Other Assets | 327.755 M | 321.255 M | 332.264 M | 333.764 M | 343.638 M | 349.177 M | 358.920 M | 362.390 M | |
| Intangible Assets | 100.594 M | 99.968 M | 97.672 M | 94.361 M | 90.932 M | 87.129 M | 84.500 M | 115.352 M | |
| Goodwill | 355.528 M | 355.292 M | 361.795 M | 362.942 M | 364.206 M | 361.766 M | 365.961 M | 408.672 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.607 B | 2.640 B | 2.747 B | 2.808 B | 2.871 B | 3.086 B | 3.260 B | 3.354 B | |
| Total liabilities | 2.150 B | 2.164 B | 2.138 B | 1.967 B | 1.777 B | 1.789 B | 1.775 B | 1.785 B | |
| Total current liabilities | 1.167 B | 1.190 B | 1.236 B | 1.066 B | 883.859 M | 970.193 M | 951.547 M | 956.902 M | |
| Accounts Payable | 127.262 M | 110.144 M | 110.221 M | 117.709 M | 107.664 M | 112.609 M | 110.643 M | 117.462 M | |
| Other liabilities | 106.742 M | 105.695 M | 98.449 M | 101.303 M | 93.337 M | 87.927 M | 94.059 M | 94.304 M | |
| Current long term debt | 611.000 M | 633.000 M | 653.982 M | 506.486 M | 338.991 M | 399.990 M | 324.997 M | 324.998 M | |
| Long term debt | 767.995 M | 760.814 M | 694.387 M | 696.362 M | 696.844 M | 618.813 M | 622.883 M | 620.778 M | |
| Other liabilities | 106.742 M | 105.695 M | 98.449 M | 101.303 M | 93.337 M | 87.927 M | 94.059 M | 94.304 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 457.008 M | 475.999 M | 608.737 M | 841.101 M | 1.094 B | 1.297 B | 1.485 B | 1.569 B | |
| Common stock | 83.922 M | 83.247 M | 82.913 M | 82.992 M | 83.086 M | 83.097 M | 83.089 M | 83.096 M | |
| Retained earnings | 3.246 B | 3.427 B | 3.600 B | 3.814 B | 4.038 B | 4.250 B | 4.445 B | 4.680 B |